Shareholders Equity: The sum of preferred and common equity items.
Oncobiologics, Inc. (OTLK) had Shareholders Equity of $-28.99M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.13M |
|
$-4.45M |
|
$0.15M |
|
$-0.02M |
|
$14.15M |
|
$-14.03M |
|
$9.57M |
|
$-4.45M |
|
$-4.45M |
|
$-4.45M |
|
$-4.45M |
|
$-4.45M |
|
$-4.45M |
|
$-14.03M |
|
$-14.00M |
|
81.84M |
|
81.84M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$20.90M |
|
-- |
|
$0.99M |
|
$21.89M |
|
$38.88M |
|
$11.12M |
|
$12.00M |
|
$50.89M |
|
$-28.99M |
|
$-28.99M |
|
|
Shareholders Equity |
$-28.99M |
104.61M |
|
| Cash Flow Statement Financials | |
$-22.77M |
|
-- |
|
$22.43M |
|
$8.08M |
|
$7.75M |
|
$-0.33M |
|
$1.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.54 |
|
-- |
|
-- |
|
-0.62 |
|
-0.93 |
|
-17.18% |
|
-11006.82% |
|
-11006.82% |
|
-- |
|
-3494.28% |
|
-3494.28% |
|
$-22.77M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.04 |
|
0.05 |
|
1920.80 |
|
15.36% |
|
15.36% |
|
-20.34% |
|
24.92% |
|
$-0.28 |
|
$-0.28 |
|
$-0.28 |
|